234 results on '"Chandele, Anmol"'
Search Results
2. Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection
3. Viremia and clinical manifestations in acute febrile patients of Chikungunya infection during the 2016 CHIKV outbreak in Delhi, India
4. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
5. Prediction of human protein interactome of dengue virus non-structural protein 5 (NS5) and its downstream immunological implications
6. Oxidized LDL receptors: a recent update
7. Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections
8. Contrasting behavior between the three human monocyte subsets in dengue pathophysiology
9. Structural Profiles of SARS-CoV-2 Variants in India
10. Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India
11. Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates.
12. Functional and transcriptional heterogeneity within the massively expanding HLADR + CD38 + CD8 T cell population in acute febrile dengue patients
13. Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models : Support for at least 2 Doses
14. Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening
15. Analysis of dengue specific memory B cells, neutralizing antibodies and binding antibodies in healthy adults from India
16. Emergence of new genotypes and lineages of dengue viruses during the 2012–15 epidemics in southern India
17. Isolation and molecular characterization of dengue virus clinical isolates from pediatric patients in New Delhi
18. Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron
19. Clinical, Serological, and Virological Analysis of 572 Chikungunya Patients From 2010 to 2013 in India
20. Enhancing the sensitivity of Dengue virus serotype detection by RT-PCR among infected children in India
21. Evaluation of a pan-serotype point-of-care rapid diagnostic assay for accurate detection of acute dengue infection
22. New Technologies for Vaccine Development: Harnessing the Power of Human Immunology
23. High yield expression and purification of Chikungunya virus E2 recombinant protein and its evaluation for serodiagnosis
24. A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents
25. Neutralizing antibodies from prior exposure negatively correlate with dengue viremia and may influence serotype dominance
26. Structural Profiles of SARS-CoV-2 Variants in India
27. Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
28. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
29. Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
30. Short communication: Virological and B cell profiles of chikungunya and Dengue virus co-infections in Delhi during 2017–2019
31. Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
32. Structural insights for neutralization of BA.1 and BA.2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody
33. High-mobility group box 1 protein promotes dengue virus replication by interacting with untranslated regions of viral genome
34. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival
35. Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes
36. Immunophenotyping and Transcriptional Profiling of Human Plasmablasts in Dengue
37. Current status of therapeutic monoclonal antibodies against SARS-CoV-2
38. Dual avatars of E. coli grxB encoded Glutaredoxin 2 perform ascorbate recycling and ion channel activities
39. Structure-guided inhibitor discovery targeting a membrane receptor involved in atherosclerosis
40. Epidemiology and molecular characterization of chikungunya virus from human cases in North India, 2016
41. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
42. Molecular surveillance of Dengue Virus (DENV) and its co-infection with Chikungunya Virus (CHIKV) among febrile patients: A comparative study from South Delhi, India
43. Molecular surveillance of Dengue Virus (DENV) and its co-infection with Chikungunya Virus (CHIKV) among febrile patients: A comparative study from South Delhi, India
44. Dengue Virus Non-Structural Protein 5 as a Versatile, Multi-Functional Effector in Host–Pathogen Interactions
45. ROS-triggered caspase 2 activation and feedback amplification loop in β-carotene-induced apoptosis
46. Differential Expression of Ly6C and T-bet Distinguish Effector and Memory Th1 CD4+ Cell Properties during Viral Infection
47. Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii
48. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
49. Human immunity to chikungunya infection
50. Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.